{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:52:48Z","timestamp":1789419168946,"version":"build-2803163510"},"reference-count":15,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDS"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Crohn Disease (CD) is an intestinal inflammatory condition characterized\nby a complex pathogenesis, with elevated levels of inflammatory cytokines. Adalimumab and certolizumab\nare two biologic drugs inhibiting TNF-\u03b1.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>We report the first case of a probable relationship, according to Naranjo causality assessment\nscore, between two consecutive treatments with TNF-\u03b1 inhibitors and induced erectile\ndysfunction (ED), that disappeared after switching to another biologic drug (ustekinumab).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Case Presentation:<\/jats:title>\n<jats:p>This case report describes a possible and important association of two TNF-\u03b1\ninhibitors (certolizumab and adalimumab) and ED in a male patient with CD, with resolution after\nswitching to Ustekinumab (anti-interleukin 12 and 23 biologic drug). A 65 years old man experienced\nerectile dysfunction during treatment with an anti-TNF. The adverse effect disappeared after\ndiscontinuation of the drug. All necessary urologic exams were carried out. Adalimumab was replaced\nby certolizumab and sexual disfunction symptoms appeared again, improving typically at\nthe end of treatment periods and getting worse with each new dose.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Switching to ustekinumab lead to a resolution of the erectile dysfunction.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>We describe for the first time a sexual dysfunction possibly due to two similar anti\nTNF drugs and its resolution after the switch to another similar but different drug, highlighting the\npotential difference between biologic drugs.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574886317666220429111341","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T12:44:06Z","timestamp":1652100246000},"page":"374-378","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Rare Case of Drug-induced Erectile Dysfunction with Adalimumab and\nCertolizumab Solved after Switch to Ustekinumab in a Crohn's Disease\nPatient"],"prefix":"10.2174","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3050-7916","authenticated-orcid":true,"given":"Samuel","family":"Hidalgo-Rios","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, University Hospital Virgen del Rocio, Av Manuel Siurot, Sevilla S\/n 41013,\nSpain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Alonso-Moreno","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University Hospital Virgen del Rocio, Av Manuel Siurot, Sevilla S\/n 41013, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime Torell\u00f3","family":"Iserte","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, University Hospital Virgen del Rocio, Av Manuel Siurot, Sevilla S\/n 41013,\nSpain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Manuel","family":"Herrera-Justiniano","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Hospital Virgen del Rocio, Av Manuel Siurot, Sevilla S\/n 41013, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.mayocp.2017.04.010","volume":"92","author":"Feuerstein J.D.","year":"2017","unstructured":"Feuerstein J.D.; Cheifetz A.S.; Cheifetz A.S.; Crohn disease: Epidemiology, diagnosis, and management. Mayo Clin Proc 2017,92(7),1088-1103","journal-title":"Mayo Clin Proc"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13062-020-00280-5","volume":"15","author":"Petagna L.","year":"2020","unstructured":"Petagna L.; Antonelli A.; Ganini C.; Pathophysiology of Crohn\u2019s disease inflammation and recurrence. Biol Direct 2020,15(1),23","journal-title":"Biol Direct"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1001\/jama.2020.18936","volume":"325","author":"Cushing K.","year":"2021","unstructured":"Cushing K.; Higgins P.D.R.; Management of Crohn disease: A review. JAMA 2021,325(1),69-80","journal-title":"JAMA"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/apt.12749","volume":"39","author":"Stidham R.W.","year":"2014","unstructured":"Stidham R.W.; Lee T.C.H.; Higgins P.D.R.; Systematic review with network meta-analysis: The efficacy of anti-TNF agents for the treatment of Crohn\u2019s disease. Aliment Pharmacol Ther 2014,39(12),1349-1362","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s10067-014-2858-x","volume":"34","author":"Kreitenberg A.J.","year":"2015","unstructured":"Kreitenberg A.J.; Ortiz E.C.; Arkfeld D.G.; Priapism after tumor necrosis factor alpha inhibitor use. Clin Rheumatol 2015,34(4),801-802","journal-title":"Clin Rheumatol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/ijir.2009.44","volume":"21","author":"Oh J.S.","year":"2009","unstructured":"Oh J.S.; Heo H.M.; Kim Y.G.; Lee S.G.; Lee C.K.; Yoo B.; The effect of anti-tumor necrosis factor agents on sexual dysfunction in male patients with ankylosing spondylitis: A pilot study. Int J Impot Res 2009,21(6),372-375","journal-title":"Int J Impot Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"16003","DOI":"10.1038\/nrdp.2016.3","volume":"2","author":"Yafi F.A.","year":"2016","unstructured":"Yafi F.A.; Jenkins L.; Albersen M.; Erectile dysfunction. Nat Rev Dis Primers 2016,2(1),16003","journal-title":"Nat Rev Dis Primers"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1093\/eurheartj\/ehl341","volume":"27","author":"Vlachopoulos C.","year":"2006","unstructured":"Vlachopoulos C.; Aznaouridis K.; Ioakeimidis N.; Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. Eur Heart J 2006,27(22),2640-2648","journal-title":"Eur Heart J"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1056\/NEJM200006153422407","volume":"342","author":"Lue T.F.","year":"2000","unstructured":"Lue T.F.; Erectile dysfunction. N Engl J Med 2000,342(24),1802-1813","journal-title":"N Engl J Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1111\/j.1743-6109.2010.01762.x","volume":"7","author":"Carneiro F.S.","year":"2010","unstructured":"Carneiro F.S.; Webb R.C.; Tostes R.C.; Emerging role for TNF-&#x3B1; in erectile dysfunction. J Sex Med 2010,7(12),3823-3834","journal-title":"J Sex Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/andr.12366","volume":"5","author":"Semet M.","year":"2017","unstructured":"Semet M.; Paci M.; Sa&#xEF;as-Magnan J.; The impact of drugs on male fertility: A review. Andrology 2017,5(4),640-663","journal-title":"Andrology"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2174\/1574886314666190726155147","volume":"15","author":"Dastoli S.","year":"2020","unstructured":"Dastoli S.; Iannone L.F.; Bennardo L.; A rare case of drug-induced erectile dysfunction with secukinumab solved after switch to ixekizumab in a psoriatic patient: A case report. Curr Drug Saf 2020,15(1),69-72","journal-title":"Curr Drug Saf"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1136\/annrheumdis-2011-200890","volume":"71","author":"Keller J.J.","year":"2012","unstructured":"Keller J.J.; Lin H.C.; A population-based study on the association between rheumatoid arthritis and erectile dysfunction. Ann Rheum Dis 2012,71(6),1102-1103","journal-title":"Ann Rheum Dis"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"H1016","DOI":"10.1152\/ajpheart.00779.2004","volume":"288","author":"Vila E.","year":"2005","unstructured":"Vila E.; Salaices M.; Cytokines and vascular reactivity in resistance arteries. Am J Physiol Heart Circ Physiol 2005,288(3),H1016-H1021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"Naranjo C.A.","year":"1981","unstructured":"Naranjo C.A.; Busto U.; Sellers E.M.; A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981,30(2),239-245","journal-title":"Clin Pharmacol Ther"}],"container-title":["Current Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574886317666220429111341","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/204274\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574886317666220429111341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T15:06:38Z","timestamp":1691334398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/204274\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574886317666220429111341","relation":{},"ISSN":["1574-8863"],"issn-type":[{"value":"1574-8863","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-07-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}